Factors influencing long-term outcome after kidney transplantation

Transplant International

Volumn 27, Issue 1, 2014, Pages 19-27

  Legendre, Christophe ^a,b   Canaud, Guillaume ^a,b   Martinez, Frank ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

antibody mediated rejection; cardiovascular mortality; delayed graft function; donor specific antibodies; graft function; kidney donor

Indexed keywords

ACUTE GRAFT REJECTION; ANTIBODY MEDIATED REJECTION; BLOOD COMPATIBILITY; COMORBIDITY; DELAYED GRAFT FUNCTION; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; REVIEW;

ANTIBODY-MEDIATED REJECTION; CARDIOVASCULAR MORTALITY; DELAYED GRAFT FUNCTION; DONOR-SPECIFIC ANTIBODIES; GRAFT FUNCTION; KIDNEY DONOR;

AGE FACTORS; AGED; CREATININE; DELAYED GRAFT FUNCTION; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSION; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; PROTEINURIA; RECURRENCE; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896545377     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12217     Document Type: Review

References (67)

1. Lamb KE, Lodhi S, Meier-Kriesche HU,. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2012; 11: 450.
2. Gondos A, Döhler B, Brenner H, Opelz G,. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation 2013; 95: 267.
3. El-Zoghby ZM, Stegall MD, Lager DJ, et al,. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527.
4. Matas AJ, Smith JM, Skeans MA, et al,. OPTN/SRTR 2011 Annual Data Report kidney. Am J Transplant 2013; 23 (Suppl. 1): 11.
5. Rao PS, Ojo A,. The alphabet soup of kidney transplantation: SCD, DCD, ECD. Fundamentals for the practicing nephrologist. Clin J Am Soc Nephrol 2009; 4: 1827.
6. Pascual J, Zamora J, Pirsch JD,. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008; 52: 553.
7. Port FK, Bragg-Gresham JL, Metzger RA, et al,. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281.
8. Nyberg SL, Matas AJ, Kremers WK, et al,. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant 2003; 3: 715.
9. Schold JD, Howard RJ, Scicchitano MJ, Meier-Kriesche HU,. The expanded criteria donor policy: an evaluation of program objectives and indirect ramifications. Am J Transplant 2006; 6: 1689.
10. Hoogland ER, Snoeijs MG, van Heurn LW,. DCD kidney transplantation: results and measures to improve outcome. Curr Opin Organ Transplant 2010; 15: 177.
11. Remuzzi G, Cravedi P, Perna A, et al,. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006; 354: 343.
12. Anglicheau D, Loupy A, Lefaucheur C, et al,. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant 2008; 8: 2325.
13. Frei U, Noeldeke J, Machold-Fabrizii V, et al,. Prospective age-matching in elderly kidney transplant recipients: a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50.
14. Boesmuller C, Biebl M, Scheidl S, et al,. Long-term outcome in kidney transplant recipients over 70 years in the Eurotransplant Senior Kidney Transplant Program: a single center experience. Transplantation 2011; 92: 210.
15. Knoll GA,. Kidney transplantation in the older adult. Am J Kidney Dis 2013; 61: 790.
16. Challimpamontree W, Dmitrienko S, Li G, et al,. Probability, predictors, and prognosis of post-transplantation glomerulonephritis. J Am Soc Nephrol 2009; 20: 843.
17. Canaud G, Audard V, Kofman T, Lang P, Legendre C, Grimbert P,. Recurrence from primary and secondary glomerulopathy after renal transplant. Transpl Int 2012; 25: 812.
18. Floege J, Gröne HJ,. Recurrent IgA nephropathy in the renal allograft: not a benign condition. Nephrol Dial Transplant 2013; 28: 1070.
19. Legendre CM, Licht C, Muus P, et al,. Terminal complement inhibitor eculizumab in atypical Hemolytic-Uremic Syndrome. N Engl J Med 2013; 368: 2169.
20. Johnson RJ, Fuggle SV, Mumford L, et al,. A new UK 2006 National Kidney Allocation Scheme for deceased heart-beating donor kidneys. Transplantation 2010; 89: 387.
21. Süsal C, Opelz G,. Current role of human leukocyte antigen in kidney transplantation. Curr Opin Organ Transplant 2013; 18: 438.
22. Foster BJ, Dahhou M, Zhang X, Platt RW, Hanley JA,. Relative importance of HLA mismatch and donor age to graft survival in young transplant recipients. Transplantation 2013; 96: 469.
23. Terasaki PI,. A personal perspective: 100-year history of the humoral theory of transplantation. Transplantation 2012; 93: 751.
24. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al,. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008; 8: 324.
25. Lefaucheur C, Loupy A, Hill GS, et al,. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010; 21: 1398.
26. Mohan S, Palanisamy A, Tsapepas D, et al,. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 2012; 23: 2061.
27. Opelz G, Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 1570.
28. Giral M, Foucher Y, Dufay A, et al,. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant 2013; 13: 2567.
29. Sellares J, de Freitas DG, Mengel M, et al,. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 2012; 12: 388.
30. Malek SK, Keys BJ, Kumar S, Milford E, Tullius SG,. Racial and ethnic disparities in kidney transplantation. Transpl Int 2011; 24: 419.
31. Pallet N, Thervet E, Alberti C, et al,. Kidney transplant in black recipients: are African Europeans different from African Americans. Am J Transplant 2005; 5: 2682.
32. Meier-Kriesche HU, Schold JD,. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial 2005; 18: 499.
33. Jardine AG, Gaston RS, Fellström BC, Holdaas H,. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet 2011; 378: 1419.
34. Cavaillé-Coll M, Bala S, Velidedeoglu E, et al,. Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. Am J Transplant 2013; 13: 1134.
35. Yarlagadda SG, Coca SG, Garg AX, et al,. Marked variation in the definitions and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008; 23: 2995.
36. Sharif A, Borrows R,. Delayed graft function after kidney transplantation: the clinical perspective. Am J Kidney Dis 2013; 62: 150.
37. Kayler LK, Magliocca J, Zendejas I, et al,. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant 2011; 11: 2647.
38. Kayler LK, Srinivas TR, Schold JD,. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant 2001; 11: 2657.
39. Moers C, Smits JM, Maathuis MH, et al,. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7-19.
40. O'Callaghan JM, Morgan RD, Knight SR, et al,. Systematic review and meta-analysis of hypothermic machine perfusion versus static storage of kidney allografts on transplant outcomes. Br J Surg 2013; 100: 991.
41. O'Callaghan JM, Knight SR, Morgan RD, et al,. Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant 2012; 12: 896.
42. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP,. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311.
43. Kasiske BL, Israni AK, Snyder JJ, et al,. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 2011; 57: 466.
44. Meier-Kriesche HU, Baliga R, Kaplan B,. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291.
45. Fellström B, Jardine AG, Soveri I, et al,. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant 2005; 5: 1986.
46. Weiner DE, Carpenter MA, Levey AS, et al,. Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. Am J Transplant 2012; 12: 2437.
47. Halimi JM,. Low-grade proteinuria and microalbuminuria in renal transplantation. Transplantation 2013; 96: 121.
48. Legendre Ch, Anglicheau D,. Transplantation: Proteinuria in kidney transplantation: an ongoing story. Nat Rev Nephrol 2013; 9: 251.
49. Ekberg H, Johansson ME,. Challenges and considerations in diagnosing the kidney disease in deteriorating graft function. Transpl Int 2012; 25: 1119.
50. Nankivell BJ, Kuypers DJ,. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011; 378: 1428.
51. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR,. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
52. Snanoudj R, Royal V, Elie C, et al,. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant 2011; 11: 2635.
53. Gaston RS,. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clin J Am Soc Nephrol 2009; 4: 2029.
54. Naesens M, Kuypers DR, Sarwal M,. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc nephrol 2009; 4: 481.
55. Chapman JR,. Chronic calcineurin inhibitor nephrotoxicity-Lest we forget. Am J Transplant 2011; 11: 693.
56. Matas AJ,. Chronic progressive calcineurin nephrotoxicity: an overstated concept. Am J Transplant 2011; 11: 687.
57. Loupy A, Jordan SC,. Transplantation: donor-specific HLA antibodies and renal allograft failure. Nat Rev Nephrol 2013; 9: 130.
58. Worthington JE, McEwen A, McWilliam MJ, Picton ML, Martin S,. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies and graft outcome. Transplantation 2007; 83: 398.
59. Lachmann N, Terasaki PI, Budde K, et al,. Anti-human leukocyte antigen and donor-specific antibodies detected by Luminex post-transplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87: 1505.
60. Wiebe C, Gibson IW, Blydt-Hansen TD, et al,. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012; 12: 1157.
61. Loupy A, Lefaucheur C, Vernerey D, et al,. Complement-binding anti-HLA antibodies and kidney allograft survival. N Engl J Med 2013; 369: 1215.
62. Lefaucheur C, Loupy A, Vernerey D, et al,. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 2013; 381: 313.
63. Sharif A, Baboolal K,. Complications associated with new-onset diabetes after kidney transplantation. Nat Rev Nephrol 2011; 8: 34.
64. Hecking M, Werzowa J, Haldinger M, et al,. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant 2013; 28: 550.
65. Webster AC, Wong G, Craig JC, Chapman JR,. Managing cancer risk and decision making after kidney transplantation. Am J Transplant 2008; 8: 2185.
66. Colett D, Mumford L, Banner NR, Neuberger J, Watson C,. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Transplant 2010; 10: 1889.
67. Schäfer-Keller P, Steiger J, Bock A, et al,. Diagnostic accuracy of measurements methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008; 8: 616.